Who is sponsoring ACTIVATE?

ACTIVATE is sponsored by AstraZeneca.

What condition does ACTIVATE study?

ACTIVATE studies Pulmonary Disease, Chronic Obstructive.

What drugs are being tested in ACTIVATE?

Interventions: Aclidinium/Formoterol, Placebo.

What is the status of ACTIVATE?

ACTIVATE is currently COMPLETED.

Last reviewed 2018-10-09 · How we verify

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients (ACTIVATE)

NCT02424344 PHASE4 COMPLETED Results posted

The present study is planned to evaluate the effect of the aclidinium bromide/formoterol fumarate 400/12 μg FDC BID on the hyperinflation, exercise endurance and physical activity in patients with moderate to severe COPD. Additionally, the effect of the behavioural intervention on top of aclidinium bromide/formoterol fumarate 400/12 μg will be assessed both on the exercise endurance and the physical activity.

Details

Lead sponsor	AstraZeneca
Phase	PHASE4
Status	COMPLETED
Enrolment	267
Start date	Mon Apr 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jul 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Aclidinium/Formoterol
Placebo

Countries

Spain, Canada, Germany, Hungary